Where is Cannabis Legal in the United States?

Cannabis Legal Status in 2026: The Federal Shake-Up and Where the States Stand

A plain-English read on rescheduling, the hemp cliff, and how the legal map actually looks across the country as of April 2026.

It has been roughly 30 years since California legalized medical cannabis in 1996, and the map of American marijuana laws looks almost nothing like it did back then. What started as one state’s bold experiment has grown into a patchwork of 25 states plus Washington, D.C. that allow adult-use sales, another 14 with medical-only programs, and a shrinking handful of holdouts where any form of possession is still a crime.

But 2026 is shaping up to be the most consequential year for federal cannabis policy since the Controlled Substances Act passed in 1970. A presidential executive order, a brewing fight over hemp-derived products, and a handful of states on the verge of joining or leaving the legal column mean the landscape a year from now could look meaningfully different. Here is what is happening and where every state stands as of April 2026.

The Federal Picture in 2026

Cannabis is still a Schedule I controlled substance under federal law. That is the same category as heroin, and officially it means the federal government treats marijuana as a drug with high abuse potential and no accepted medical use — a classification that feels increasingly disconnected from the 39 states now running some form of legal cannabis program.

That could change soon. On December 18, 2025, President Trump signed Executive Order 14370, instructing the Attorney General and the DEA to finish the rulemaking that moves marijuana to Schedule III. Rescheduling would not legalize recreational cannabis at the federal level and would not override state laws, but it would do three practically important things: acknowledge that cannabis has accepted medical uses, eliminate the punishing Section 280E tax rule that has forced licensed cannabis businesses to pay income tax on gross revenue, and modestly loosen the research restrictions that have held back clinical studies for decades.

Whether and when that actually takes effect is another matter. The DEA still has to complete an administrative hearing process, and there is no firm deadline. Some legal analysts expect a final rule in 2026; others think it could slip into 2027 or get tangled up in litigation.

Two other federal moves deserve attention. A new definition of hemp takes effect in November 2026, switching from a 0.3% delta-9 THC limit to a 0.3% total THC limit and capping hemp-derived products at 0.4 milligrams of THC per container. If the law goes into force as written, a huge share of today’s hemp-derived gummies, vapes, and drinks will become illegal overnight — a cliff edge that retailers and manufacturers are scrambling to prepare for. Separately, in February 2026, the Trump administration signed appropriations that again block Washington, D.C. from setting up legal recreational sales, despite possession being legal in the District since 2014.

In short: Washington is finally moving, but not in a single direction. For consumers and patients, the state-by-state map remains what matters.

How to Read the State Map in 2026

States fall into four broad buckets. The widget below lets you look up any state individually; this section explains the categories and flags the states worth watching.

Twenty-five states plus Washington, D.C. now allow adults 21 and older to buy cannabis at a licensed dispensary, though possession limits and home-grow rules vary widely. The group keeps growing — Ohio launched retail sales in August 2024, Delaware followed in 2024, Minnesota opened its market in 2025, and Virginia finally passed retail legislation in March 2026 that opens adult-use sales on January 1, 2027 after five years of legal-possession-but-no-legal-purchase limbo. Hawaii legalized in 2025 but is still building its retail framework; sales are expected in late 2026 or 2027.

Another 14 states run medical-only programs. The story here is mixed. Kentucky launched its program on January 1, 2026 and is already seeing strong patient demand. Nebraska’s voter-approved 2024 measure has been tangled in lawsuits and restrictive rulemaking; as of April 2026, regulations have finally been finalized but patient access is still limited. Pennsylvania has a large medical program and an increasingly noisy recreational debate — Governor Shapiro backs legalization, and with neighbors New Jersey, New York, Maryland, and Ohio all operating adult-use markets, economic pressure is mounting. Most analysts expect Pennsylvania to flip in 2026 or 2027.

Six states fall into a “limited medical” category — they have some kind of official framework, but it is narrowly restricted to low-THC oils, CBD products, or specific qualifying conditions. Texas, Georgia, Iowa, Indiana, Tennessee, and Wisconsin all fit here. Wisconsin is the newest addition, having enacted a restrictive low-THC program in 2025 — notable mostly because every one of its neighbors (Minnesota, Michigan, Illinois) now has full recreational sales. Texas is also worth flagging for a different reason: it runs a narrow Compassionate Use Program but has become a major gray market for federally legal hemp-derived THC products, which the November 2026 hemp law will reshape dramatically.

Five states remain fully illegal with no meaningful medical pathway: Idaho, Kansas, North Carolina, South Carolina, and Wyoming. In most of these, federally legal hemp-derived CBD is the only cannabinoid a resident can legally buy. Citizen petition drives are active in Idaho in 2026, but realistic movement in any of these states looks unlikely before 2027 at the earliest.

Use the interactive tool below to look up your state’s specific possession limits, home-grow rules, and current status.

What’s Likely to Change in the Next 12 Months

A few developments to watch between now and April 2027. Federal rescheduling — if the DEA finalizes the Schedule III rule, expect a major shift in cannabis business economics (the end of 280E alone is enormous) even though consumer-facing state laws would be largely unchanged. The November 2026 hemp cliff — unless Congress acts to delay or modify the new hemp definition, a significant portion of today’s hemp-derived THC products become illegal on day one. Pennsylvania recreational — the political and economic pressure makes a legalization bill likely, though the mechanics (and timing) are still unclear. Nebraska — a recreational ballot measure may appear in November 2026, and the medical program’s implementation continues to be heavily contested. Virginia retail launch — January 1, 2027 brings sales to one of the largest states without an active adult-use market.

One thing is not going to change: crossing state lines with cannabis remains a federal crime, even between two states where it is legal. Keep your supply at home when you travel — rescheduling does not fix this, and likely will not for years.

The Bottom Line

In 2022, the national cannabis conversation was still framed by whether legalization “worked.” In 2026, that question is largely settled — most Americans live in states where some form of legal cannabis is available, and the federal government is formally acknowledging medical legitimacy for the first time in a half-century. The remaining battles are about details: how rescheduling gets implemented, whether the hemp industry survives the new definition, and which of the last holdout states moves next.

The information here reflects the legal landscape as of April 2026. Laws change quickly — always verify with your state’s official resources before acting. If you have questions about your particular state, drop them in the comments and we’ll help where we can.